CD3⁺CD4⁻CD8⁻ (Double-Negative) T-cells Provide Inflammatory Signals That Influence Myeloid Cells and Enhance Survival in Glioblastoma

Glioblastoma (GBM) remains resistant to immunotherapy, in part because of a profoundly immunosuppressive tumor microenvironment. While investigating the consequences of conventional T-cell depletion in a murine glioma model, we unexpectedly identified a population of double-negative T-cells (DNTs; CD3⁺CD4⁻CD8⁻) that persisted following combined depletion of CD4⁺ and CD8⁺ T-cells. DNT enrichment was associated with significantly prolonged survival and revealed a distinct inflammatory transcriptional program characterized by activation-associated gene expression. Single-cell transcriptomic analyses demonstrated extensive remodeling of the glioma myeloid compartment, including enrichment of inflammatory signaling pathways and reduced expression of immunosuppressive markers. In complementary human studies, unmodified healthy donor-derived DNTs suppressed glioma stem cell viability, enhanced macrophage phagocytic activity, and reduced expression of the inhibitory myeloid receptor LAIR1. Intracranial administration of these unmodified DNTs significantly prolonged survival compared with PanT cells in an orthotopic glioblastoma xenograft model.. Collectively, these findings identify DNTs as previously underappreciated regulators of glioblastoma immunity that exert antitumor effects through both direct tumor suppression and inflammatory remodeling of the glioma myeloid compartment. These results support further investigation of DNT-based cellular therapies for the treatment of glioblastoma.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-18
DOI
https://doi.org/10.64898/2026.11.16.767095
Primary Topic
Glioma Diagnosis and Treatment
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

CD3⁺CD4⁻CD8⁻ (Double-Negative) T-cells Provide Inflammatory Signals That Influence Myeloid Cells and Enhance Survival in Glioblastoma

Hinda Najem, Khatri Latha, Yeunjung Ko, Malcolm F. McDonald et al.
5 links
bioRxiv (Cold Spring Harbor Laboratory)
Glioma Diagnosis and Treatment
preprint

CD3⁺CD4⁻CD8⁻ (Double-Negative) T-cells Provide Inflammatory Signals That Influence Myeloid Cells and Enhance Survival in Glioblastoma

Hinda Najem, Khatri Latha, Yeunjung Ko, Malcolm F. McDonald, Jack R Tremblay, Yuhui Yang, Arya J. Shetty, Benjamin Deneen, Akdes Serin Harmancı, Rebecca L. Murdaugh, Rajan Patel, Amy B. Heimberger, Jamie N. Anastas, Eric A. Goethe, Ganesh S. Rao, Harrshavasan T. S. Congivaram, Ashley Puentes, Yi-Cian Zheng, Rouchen Du
preprint en

Abstract

Glioblastoma (GBM) remains resistant to immunotherapy, in part because of a profoundly immunosuppressive tumor microenvironment. While investigating the consequences of conventional T-cell depletion in a murine glioma model, we unexpectedly identified a population of double-negative T-cells (DNTs; CD3⁺CD4⁻CD8⁻) that persisted following combined depletion of CD4⁺ and CD8⁺ T-cells. DNT enrichment was associated with significantly prolonged survival and revealed a distinct inflammatory transcriptional program characterized by activation-associated gene expression. Single-cell transcriptomic analyses demonstrated extensive remodeling of the glioma myeloid compartment, including enrichment of inflammatory signaling pathways and reduced expression of immunosuppressive markers. In complementary human studies, unmodified healthy donor-derived DNTs suppressed glioma stem cell viability, enhanced macrophage phagocytic activity, and reduced expression of the inhibitory myeloid receptor LAIR1. Intracranial administration of these unmodified DNTs significantly prolonged survival compared with PanT cells in an orthotopic glioblastoma xenograft model.. Collectively, these findings identify DNTs as previously underappreciated regulators of glioblastoma immunity that exert antitumor effects through both direct tumor suppression and inflammatory remodeling of the glioma myeloid compartment. These results support further investigation of DNT-based cellular therapies for the treatment of glioblastoma.

bioRxiv (Cold Spring Harbor Laboratory)
Northwestern University (US), Baylor College of Medicine (US)
Good health and well-being
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon